Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06128863 |
| Title | Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial (EFTISARC-NEO) |
| Acronym | EFTISARC-NEO |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Maria Sklodowska-Curie National Research Institute of Oncology |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | POL |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Maria Sklodowska-Curie National Research Institute of Oncology | RECRUITING | Warsaw | 00-738 | Poland | Details |